Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Revenue (2024)

Compass Therapeutics' Revenue history spans 1 years, with the latest figure at $850000.0 for Q2 2024.

  • On a quarterly basis, Revenue changed N/A to $850000.0 in Q2 2024 year-over-year; TTM through Jun 2025 was $850000.0, a 0.0% change, with the full-year FY2024 number at $850000.0, changed N/A from a year prior.
  • Revenue hit $850000.0 in Q2 2024 for Compass Therapeutics.
  • Over the last five years, Revenue for CMPX hit a ceiling of $850000.0 in Q2 2024 and a floor of $850000.0 in Q2 2024.